Skip to main content
FinSpry Logo
FinSpry
TVTX logo
TVTX
(NASDAQ)
Travere Therapeutics, Inc.
$30.44-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Travere Therapeutics (TVTX) Stock Price & Financial Analysis

Travere Therapeutics Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$30.22 - $31.35
52-Week High$42.13
52-Week Low$12.91
Open$30.69
Volume1.15M
Average Volume (3M)1.15M
Market Cap2.72B
Shares Outstanding89.21M
Price to Sales (P/S)5.71
Price to Book (P/B)24.41
EV/EBITDA136.76
Revenue (TTM)490.73M
Net Income (TTM)-50.26M
Free Cash Flow (TTM)-1.13M
EPS (TTM)$-0.56
Profit Margin-10.24%
Operating Margin-12.80%
Return on Equity (ROE)-43.77%
Debt to Equity2.86
50-Day MA$29.17
200-Day MA$26.43
52-Week Change80.16%
Annual Dividend$0.00
Dividend Yield0.00%

Frequently Asked Questions About Travere Therapeutics

What is the current stock price for TVTX?

As of the latest trading session, TVTX stock trades at $30.44. The 52-week range is $12.91–$42.13, with a day range of $30.22–$31.35.

What is the P/E ratio for TVTX?

The P/E ratio (Price-to-Earnings) for TVTX is shown in the Key Statistics section. This valuation metric helps compare Travere Therapeutics, Inc. to industry peers.

Does TVTX pay dividends?

Travere Therapeutics does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for TVTX?

Based on 2 analysts, the consensus for TVTX is Buy. The average 12-month price target is $NaN, representing a NaN% downside from the current price.

What is the market cap of TVTX?

Travere Therapeutics's market capitalization is $2.72B, classifying it as a mid-cap company. Travere Therapeutics operates in the Healthcare sector within the Biotechnology industry.